Sirolimus

Educational summary, not a formulary. Dosing is quoted from the Makindo chapters and topics site. The other sections are draft summaries not yet checked line by line against the BNF or SPC. Check dose, indication, interactions and monitoring in the BNF entry for Sirolimus and local guidelines before prescribing.

mTOR inhibitor

Mechanism

mTOR inhibitor immunosuppressant.

Uses

Renal transplant rejection prophylaxis, lymphangioleiomyomatosis.

Dosing

No dose is given in the chapters. See the BNF.

Side effects

Hyperlipidaemia, impaired wound healing, proteinuria, mouth ulcers, infection.

Interactions

CYP3A4 and P-gp inhibitors and inducers; ciclosporin increases nephrotoxicity.

Contraindications and cautions

Active infection

Monitoring

Levels, lipids, proteinuria

Pregnancy and breastfeeding

Avoid

Renal and hepatic impairment

Reduce dose in hepatic impairment

Overdose and reversal

Supportive

Special advice

Trough levels; avoid early use after liver transplant.

More from the textbook: uses, cautions and other points
Where it is discussed in the book